Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Reata Pharmaceuticals Inc...

    NASDAQ: RETA · Real-Time Price · USD
    172.36
    0.04 (0.02%)
    At close: Sep 25, 2023, 10:00 PM

    Reata Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 42.31M 590.26M
    Short-Term Investments
    		 345.2M n/a
    Long-Term Investments
    		 n/a n/a
    Other Long-Term Assets
    		 284K 160K
    Receivables
    		 n/a n/a
    Inventory
    		 n/a n/a
    Other Current Assets
    		 10.26M 6.22M
    Total Current Assets
    		 397.77M 596.48M
    Property-Plant & Equipment
    		 116.44M 138.38M
    Goodwill & Intangibles
    		 n/a n/a
    Total Long-Term Assets
    		 116.72M 138.54M
    Total Assets
    		 514.49M 735.02M
    Account Payables
    		 18.71M 13.51M
    Deferred Revenue
    		 n/a 1.65M
    Short-Term Debt
    		 2.15M 3.14M
    Other Current Liabilities
    		 38.1M 35.7M
    Total Current Liabilities
    		 58.96M 53.99M
    Long-Term Debt
    		 117.31M 132.89M
    Other Long-Term Liabilities
    		 403.91M 362.14M
    Total Long-Term Liabilities
    		 521.23M 495.03M
    Total Liabilities
    		 580.19M 549.03M
    Total Debt
    		 119.46M 136.03M
    Common Stock
    		 37K 36K
    Retained Earnings
    		 -1.57B -1.26B
    Comprehensive Income
    		 n/a n/a
    Shareholders Equity
    		 -65.69M -1.26B
    Total Investments
    		 345.2M n/a

    Add to Watchlist